Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working
Conditions: Locally Advanced Leiomyosarcoma; Metastatic Leiomyosarcoma; Stage III Uterine Corpus Leiomyosarcoma AJCC v8; Stage IV Uterine Corpus Leiomyosarcoma AJCC v8; Unresectable Leiomyosarcoma; Uterine Corpus Leiomyosarcoma Interventions: Drug: Olaparib; Drug: Temozolomide; Drug: Trabectedin; Drug: Pazopanib Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials